161 related articles for article (PubMed ID: 32103925)
1. Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study.
Suerdem M; Gunen H; Akyildiz L; Cilli A; Ozlu T; Uzaslan E; Abadoglu O; Bayram H; Cimrin AH; Gemicioglu B; Misirligil Z
Int J Chron Obstruct Pulmon Dis; 2020; 15():261-267. PubMed ID: 32103925
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States.
Diette GB; Dalal AA; D'Souza AO; Lunacsek OE; Nagar SP
Int J Chron Obstruct Pulmon Dis; 2015; 10():415-22. PubMed ID: 25759574
[TBL] [Abstract][Full Text] [Related]
3. Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study.
Gunen H; Yilmaz M; Aktas O; Ergun P; Ortakoylu MG; Demir A; Cetinkaya P; Gurgun A; Otlu M; Cilli A; Yilmaz U; Kokturk N; Candemir I; Yakar HI; Ar I; Konya A
Int J Chron Obstruct Pulmon Dis; 2015; 10():2485-94. PubMed ID: 26622176
[TBL] [Abstract][Full Text] [Related]
4. Geographic differences in clinical characteristics and management of COPD: the EPOCA study.
Miravitlles M; Murio C; Tirado-Conde G; Levy G; Muellerova H; Soriano JB; Ramirez-Venegas A; Ko FW; Canelos-Estrella B; Giugno E; Bergna M; Chérrez I; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):803-14. PubMed ID: 19281096
[TBL] [Abstract][Full Text] [Related]
5. Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist.
Stafyla E; Kotsiou OS; Deskata K; Gourgoulianis KI
Int J Chron Obstruct Pulmon Dis; 2018; 13():487-498. PubMed ID: 29440886
[TBL] [Abstract][Full Text] [Related]
6. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.
Sen E; Guclu SZ; Kibar I; Ocal U; Yilmaz V; Celik O; Cimen F; Topcu F; Orhun M; Tereci H; Konya A; Ar I; Saryal S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2657-63. PubMed ID: 26715844
[TBL] [Abstract][Full Text] [Related]
7. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.
Ivanov Y; Nikolaev I; Nemeth I
Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539
[TBL] [Abstract][Full Text] [Related]
8. Consequences of Changing the GOLD Reports (2007-2011-2017) on the Treatment Regimen of Patients with COPD.
Brożek GM; Nowak M; Zejda JE; Jankowski M; Lawson J; Pierzchała W
COPD; 2019 Apr; 16(2):126-132. PubMed ID: 31161814
[TBL] [Abstract][Full Text] [Related]
9. A case scenario study for the assessment of physician's behavior in the management of COPD: the WHY study.
Kilinc O; Konya A; Akgun M; Uzaslan E; Sayiner A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2751-2758. PubMed ID: 30233165
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological approach and adherence to treatment recommendations in frequently and non-frequently exacerbating COPD patients from Italy: MISTRAL - The prospective cohort, observational study.
Scalone G; Nava S; Ventrella F; Bussoli G; Catapano GA; Pennisi A; Dadduzio F; Schino P; Pela R; Bartezaghi M; Morini P; Porpiglia PA; Muscianisi E;
Pulm Pharmacol Ther; 2018 Dec; 53():68-77. PubMed ID: 30193866
[TBL] [Abstract][Full Text] [Related]
11. Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study.
Barrecheguren M; Monteagudo M; Ferrer J; Borrell E; Llor C; Esquinas C; Miravitlles M
Respir Med; 2016 Feb; 111():47-53. PubMed ID: 26758585
[TBL] [Abstract][Full Text] [Related]
12. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
13. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
Foda HD; Brehm A; Goldsteen K; Edelman NH
Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
[TBL] [Abstract][Full Text] [Related]
14. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
15. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
Lee JK; Rhee CK; Kim K; Ra SW; Lee JH; Jung KS; Yoo KH; Kim YI; Kim DK
Int J Chron Obstruct Pulmon Dis; 2019; 14():2639-2647. PubMed ID: 31819397
[TBL] [Abstract][Full Text] [Related]
16. COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
Savran O; Godtfredsen N; Sørensen T; Jensen C; Ulrik CS
Chron Respir Dis; 2019; 16():1479973119867949. PubMed ID: 31431060
[TBL] [Abstract][Full Text] [Related]
17. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
[TBL] [Abstract][Full Text] [Related]
18. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
19. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
20. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.
Incalzi RA; Corsonello A; Pedone C; Masotti G; Bellia V; Grassi V; Rengo F
Drugs Aging; 2006; 23(5):411-20. PubMed ID: 16823994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
